Loeschenberger, Beatrix <br/><br/>
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.  [electronic resource] 

 -  European journal of immunology  02 2018 
 - 330-343 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4141 
<br/><br/><label>Standard No.: </label>10.1002/eji.201747135  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Apoptosis<br/>CD55 Antigens--metabolism<br/>Calcineurin Inhibitors--adverse effects<br/>Cell Line<br/>Cell Survival<br/>Complement Membrane Attack Complex--metabolism<br/>Complement System Proteins--metabolism<br/>Cyclosporine--adverse effects<br/>Drug-Related Side Effects and Adverse Reactions--metabolism<br/>Female<br/>Gene Expression Regulation<br/>Graft Rejection--metabolism<br/>Humans<br/>Kidney Diseases--metabolism<br/>Kidney Transplantation<br/>Kidney Tubules--drug effects<br/>MAP Kinase Signaling System<br/>Male<br/>Membrane Cofactor Protein--metabolism<br/>Middle Aged<br/>Phosphorylation<br/>RNA, Small Interfering--genetics<br/>Suppressor of Cytokine Signaling 3 Protein--genetics<br/>Tacrolimus--adverse effects